Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oxytocin as Adjunctive Treatment of Schizophrenia
NCT01568528Phase 2Completed
- Sponsor
- Emory University
- Start
- Mar 2013
- Primary completion
- Mar 2017
- Modality
- Peptides
- Countries
- 1
01
Overview
A Phase 2 trial of oxytocin in schizophrenia, sponsored by Emory University. Started Mar 2013; status: completed.
02
Drugs
oxytocin
03
Conditions
schizophrenia
Beyond the preview
Go deeper on NCT01568528.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01568528.